Ranitidine 75 1A Pharma, 14 pcs

Instructions for use for Ranitidine 75 1A Pharma, 14 pcs

Important notes (compulsory information):

Ranitidine 75 - 1 A Pharma, 75 mg film-coated tablets. Active substance: Ranitidine. Application: For short-term treatment of heartburn. Contains lactose.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist!


Instructions for use: Information for patients
Ranitidine 75 - 1 A Pharma
Active substance: Ranitidine hydrochloride 84 mg according to ranitidine 75 mg per film tablet

Read the entire leaflet carefully before you start taking this medicine because it contains important information. Always take this medicine as described in this leaflet or just as your doctor or pharmacist is directed.

• Lift the package leaflet. You might want to read it again.
• Ask your pharmacist if you need more information or advice.
• If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not specified in this leaflet (see section 4).
• If you do not feel better or even worse after 14 days, contact your doctor.

What is in this leaflet

1. What is Ranitidin 75 - 1 A Pharma and what is it used for?
2. What should you pay attention to Pharma before taking Ranitidin 75 - 1 A?
3. How is Ranitidin 75 - 1 A to take Pharma?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. How is Ranitidin 75 - 1 A to keep a pharmaceutical?
6. Content of the pack and further information

1. What is Ranitidine 75 - 1 A Pharma and what is it used for?

Ranitidine 75 - 1 A Pharma is a gastrointestinal medium and belongs to the group of so-called histamine H2 receptor blockers that reduce the production of gastric acid.

Ranitidine 75 - 1 A Pharma Used for short-term treatment of heartburn.

If you do not feel better or even worse after 14 days, contact your doctor.

2. What should you pay attention to Pharma before taking Ranitidin 75 - 1 A?

Ranitidine 75 - 1 A Pharma may not be taken,
- if they allergic against ranitidine hydrochloride, other so-called H2 receptor antagonists or one of the section 6 other ingredients of this medicine are.

Warnings and Precautions Please talk to your doctor or pharmacist before you ranitidine 75 - 1 A Pharma take in:

• if you suffer from a heavy hepatic impairment.
• if you suffer from a renal impairment. Since Ranitidin is excreted over the kidneys, patients with renal impairment may occur to increased blood levels (see section 3 "What is Ranitidine 75 - 1 A Pharma Taking?").
• if you are under the metabolic disease "Acute Porphyrie" To suffer. Ranitidine can trigger acute porphyria seizures.
• if you have a lung disease. In older people, patients with chronic lung diseases, diabetes or in patients with weakened immune system, the risk of developing an outpatient pneumonia can be increased.
• if you are under regular medical control and / or suffer from a continuously requiring illness.
• if you are still different (recipe-ready or over-the-counter) Take in medication.
• if you are in the middle or advanced age, and you have recurred dyspeptic symptoms (upper abdominal complaints) or have recently changed.
• if you have an unintentional weight loss occurred in connection with dyspeptic symptoms.
• if you do not-steroidal analgesics (certain pain or Rheumatizers), especially if they have a history of gastric or duodenal ulcers.

The Arecord from Ranitidin 75 - 1 A Pharma Can disguise the symptoms of a malicious gastric ulcer and delay their diagnosis.

Children and adolescents
Application in children under 16 years is not recommended.

Taking Ranitidine 75 - 1 A Pharma Together with other medicines
Inform your doctor or pharmacist if you take / use other medicines, recently taken / applied / applied or intend to take / use other medicines.

Ranitidine can influence the recording, metabolism and excretion over the kidneys of other medicines. This changed pharmacokinetics may require dose adjustment of the influenced medicament or termination of treatment.

1) influencing enzyme systems:
Ranitidine in therapeutic doses does not reinforce the effects of medicines, such as: Diazepam, lidocaine, phenytoin, propranolol and theophylline. There are reports of changing prothrombine times with Cumarin anticoagulants (eg warfarin or phenprocoumon). Due to the narrow therapeutic width, closely monitoring of increased or depressed prothrombin time is recommended during simultaneous treatment with ranitidine. In targeted studies (clinical trials), impairment of the reduction of theophylline and / or an increase in the phyllin levels in plasma by ranitidine was not detected. However, there are individual reports on patients who have been observed under the common therapy with ranitidine and theophylline increases in theophylline levels and overthrests of theophylline. Therefore, with simultaneous therapy with ranitidine 75 - 1 a pharma, the theophyllin levels should be controlled and optionally a dose adjustment of theophyllin.

2) Excretion over the kidney:
At higher dosage of ranitidine 75 - 1 A Pharma (eg such used to treat the Zollinger ellison syndrome) It may result in a decrease in the excretion (tubular secretion inhibition) of procainamide and N-acetylprocainamide, which can lead to increased plasma levels of these medicines.

3) Change of pH in the stomach:
The bioavailability of certain medicaments may be impaired. This can lead to an increase in recording (so-called absorption) (eg. B. Triazolam, Midazolam) or decrease in absorption (eg Ketoconazole, Atazanavir, Delavirdine, Gebi Tinib). In the common treatment with ranitidine and glipizide increased plasma concentrations of glipizide can occur, whereby the blood sugar-lowering effect of glipizide can be reinforced. The absorption of ranitidine 75 - 1 A Pharma Can be reduced by antacid or sucralfat. Therefore, Ranitidin 75 - 1 a Pharma should be taken about 2 hours before these drugs.

Taking Ranitidine 75 - 1 A Pharma Together with foods, drinks and alcohol
Taking Ranitidine 75 - 1 A Pharma Can the alcohol effect be increased.

pregnancy and breast feeding period
If you are pregnant or breastfeeding, or if you suspect to be pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking / application of this medicine.

pregnancy
The active ingredient of Ranitidin 75 - 1 A Pharma happens the placenta (Mother cake) and thus gets into the bloodstream of the unborn child. Previous experiences with the use of ranitidine in pregnant women have no indications of harmful effects on the unborn child or pregnancy itself. However, you should basically obtain medical advice before taking medications in pregnancy. If you are pregnant, you should ranitidine 75 - 1 A Pharma Only take if your attending physician explicitly recommends this.

Lactation
The active substance goes into the breast milk. There are no studies on whether the recording of Ranitidine has harmful effects on the breast milk for the infant. You should be in lactation ranitidine 75 - 1 A Pharma Do not take unless your attending physician explicitly recommends this.

Driving ability and ability to the Bedienen of machines
Due to the properties of Ranitidine, an influence on the ability to drive or the ability to guide machines is usually not expected. However, studies on the effects of taking ranitidine on these skills are not available. In rare cases, however, side effects such as headache, dizziness and fatigue, confusion and restlessness and hallucinations may occur or it can be interacted with alcohol (see "Taking Ranitidine 75 - 1 A Pharma Together with foods, drinks and alcohol ") to increase alcohol levels with simultaneous alcohol consumption, so that their response assets and their judgment are reduced and the ability to drive and the ability to use machines may be impaired.

Ranitidine 75 - 1 A Pharma contains lactose
Please take Ranitidin 75 - 1 A Pharma Therefore, only after consulting with your doctor, if you are known to suffer from any intolerance to certain sugars.

3. How is Ranitidin 75 - 1 A to take Pharma?

Always take this medicine exactly as described in this leaflet or just according to the consultation made with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.

The recommended dose is:
Adults and adolescents over 16 years
When the complaints occur, during the day or at night, you should each 1 film tablet RANITIDIN 75 - 1 A Pharma take in. For most patients, 1-2 film-coated tablets per day are sufficient. However, up to 4 film-coated tablets may be taken within 24 hours.

Patients with impaired renal function
For users with a significantly limited renal function (Creatinine Clearance < 50 ml / min) can accumulate the active ingredient in the blood. If you suffer from a kidney function failure, you should definitely seek medical advice. After a medical advice was obtained, you should not do more than 2 Film Tablets Ranitidine 75 - 1 A Pharma take within a period of 24 hours. Take the film tablet in question with sufficient fluid (eg a glass of water). The intake can be done independently of meals. If the complaints continue to persist after a 14-day treatment or even worsen, you should be able to consult a doctor or pharmacist.

If you have a larger amount of ranitidine 75 - 1 A Pharma have taken as they should
Ranitidine 75 - 1 A Pharma Acts very targeted and there are usually no special problems after an overdose with the preparation. Nevertheless, please contact a doctor with overdosing immediately, so that he can decide on the further procedure. In case of overdose, symptomatic and supportive therapy is recommended. If necessary, the active ingredient can be removed from the plasma by hemodialysis. If you are taking ranitidine 75 - 1 A Pharma Forgot you do not take the double dose if you forgot the prior taking. If you have further questions about the application of the medicine, ask your doctor or pharmacist.

4. Which side effects are possible?

Like all medicines, this medicine can also have side effects, but they do not have to occur each other.

The frequency information on side effects is based on the following categories:
Very often:	more than 1 treated from 10
Frequently:	1 to 10 treated from 100
Occasionally:	1 to 10 treated from 1 000
Rarely:	1 to 10 treated from 10 000
Very rare:	less than 1 treated from 10 000
Not known:	Frequency on the basis of the available data does not estimate.

The following besidekungen were observed in clinical trials with ranitidine or in everyday life. Most of these side effects (and their frequency) were observed in continuous administration of higher doses:

Occasionally

• Stomach pain
• Diarrhea
• Constipation
• Nausea

Rarely

• Hypersensitivity reactions (urticaria nettle rash, Angioedema swelling on the face, fever, bronchial cramp, blood pressure drop, chest pain)
• temporary and reversible changes in liver values
• Skin rash
• Itching
• Increases in plasma reactive values (value for renal function)

Very rare

• Changes in the blood count (leukocytopenia and / or thrombocytopenia, agranulocytosis or tanks, sometimes with bone marrow hypoplasia or aaplasia reducing one, multiple or all blood cells )
• allergic shock
• Headache (sometimes strong)
• reversible involuntary movement disorders
• Fatigue
• reversible confusion states, restlessness
• Hallucinations
• Depressions
• Dizziness
• blurred See (reversible)
• Heart rhythmism (tachycardia, bradycardia and AV block)
• Vessel inflammation
• acute pancreatitis
• Lieberitis (hepatitis) with or without jaundice (mostly reversible)
• Erythema Multiforme (serious skin / mucosal reaction)
• Hair loss
• Symptoms of the musculoskeletal system such as joint and muscle aches
• Kidney infection (acute interstitial nephritis)
• reversible impotence
• Brust symptoms such as gynecomastia (magnification of the mammary gland of the man) and galactor roll (milk flow)
• Disorders in sexual behavior (libido loss)

Not known

• Laryngospasm (symbol collapse)

Message of side effects
If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. You can also effectively effect the Federal Institute for Medicines and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger Allee 3, D-53175 Bonn, website: www.bfarm.de, ads. By reporting side effects, you can help to provide more information about the security of this medicine.

5. What is Ranitidine 75 - 1 A Storage Pharma?

Keep this medicine inaccessible to children.

You must not use this medicine after the expiry date specified on the container and the outer carton to "usable until". The expiry date refers to the last day of the specified month.

Do not dispose of medicines in the wastewater. Ask your pharmacist how to dispose of the medicine if you do not use it anymore. You help to protect our environment.

6. Content of the pack and further information

What Ranitidin 75 - 1 A Pharma contains
The active ingredient is ranitidine hydrochloride.
1 film tablet contains 84 mg of ranitidine hydrochloride, corresponding to 75 mg ranitidine.

The other ingredients are:
Calcium hydrogen phosphate dihydrate, carboxymethyl starch sodium (type A) (ph.eur.), Microcrystalline cellulose, hypromellose, lactose monohydrate, Macrogol 4000, magnesium stearate (ph.eur.), Corn starch, high-disperses silica, titanium dioxide (E 171), Iron (III) -hydroxide oxide (E 172)

Like Ranitidine 75 - 1 A Pharma looks and content of the pack
Yellow, round film tablet with a one-sided breaker.
Ranitidine 75 - 1 A Pharma is in packs with 10 and 14 Film tablets available.

Pharmaceutic entrepreneur
1 A Pharma GmbH
Celts ring 1 + 3
82041 Oberhaching
Telephone: (089) 6138825-0

Manufacturer
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Bar life

This leaflet was recently revised in February 2013.

Source: Information of the leaflet
Status: 09/2014